raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:3124

Saccharopinuria

Synonyms: Hyperlysinemia type II · Saccharopine dehydrogenase deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

A rare autosomal recessive disorder of the lysine catabolism characterized by elevated levels of lysine in the cerebrospinal fluid and blood with variable degrees of saccharopinuria. Some patients present with neurological symptoms such as seizures, spastic diplegia, mild psychomotor delay, intellectual deficit, and behavioral difficulties. However, current findings suggest no causal association between isolated hyperlysinemia and neurological symptoms.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSaccharopinuriaHyperlysinemia type II · Saccharopine dehydrogenase deficiency
frSaccharopinurieDéficit en saccharopine déshydrogénase · Hyperlysinémie type II
deSaccharopinurieHyperlysinämie Typ II · Saccharopin-Dehydrogenase-Mangel
esSacaropinuriaDeficiencia de sacaropina deshidrogenasa · Hiperlisinemia tipo 2
itSaccaropinuriaDeficit di saccaropina deidrogenasi · Iperlisinemia, tipo II
nlSaccharopinurieDeficiëntie van saccharopine-dehydrogenase · Hyperlysinemie type II
ptSacaropinúriaDeficiência de sacaropina desidrogenase · Hiperlisinemia tipo II
plSacharopinuriaHiperlizynemia typu II · Niedobór dehydrogenazy sacharopiny
csSaccharopinurieHyperlysinémie, typ II · Deficit saccharopin dehydrogenázy
ukСахаропінуріяГіперлізинемія II типу · Дефіцит сахаропіндегідрогенази
zh酵母丙氨酸尿症酵母氨酸脱氢酶缺乏症
trSakaropinuriHiperlisinemi tip II · Sakaropin dehidrojenaz eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM268700Evalidated
ICD-10E72.3NTBTattributedvalidated
ICD-115C50.4NTBTindexvalidated
MONDO0010005Evalidated
MeSHC537218Evalidated
UMLSC0268556Evalidated
GARD314Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
AASSDisease-causing germline mutation(s) inAssessedHGNC:17366ENSG000000083116051137q31.32aminoadipate-semialdehyde synthase10775527[PMID]_23570448[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

19 annotations · validated 2021-08-17
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0011021Abnormality of circulating enzyme level
HP:0002161Hyperlysinemia
Frequent (79-30%)
HP:0001507Growth abnormality
HP:0003297Hyperlysinuria
HP:0004322Short stature
Occasional (29-5%)
HP:0032397Citrullinuria
HP:0100543Cognitive impairment
HP:0003131Cystinuria
HP:0002936Distal sensory impairment
HP:0011966Elevated plasma citrulline
HP:0002066Gait ataxia
HP:0001987Hyperammonemia
HP:0500151Hypercystinemia
HP:0001256Intellectual disability, mild
HP:0001268Mental deterioration
HP:0012758Neurodevelopmental delay
HP:0001250Seizure
HP:0001264Spastic diplegia
HP:0001337Tremor

Run the differential on the 2 obligate / very frequent terms

Annotation source: 33996359[PMID]_30573525[PMID]_32768327[PMID]

7

Sources for this card